BREAKING NEWS: We are pleased to announce FDA approval of LUMISIGHT™ (pegulicianine) and Lumicell™ DVS. To the hundreds of women and dedicated investigators who participated in this important clinical work that brought us to where we are today, THANK YOU! We wouldn’t be here without your support.
Close this search box.
Lumicell Surgeon 1
Illuminate residual
cancer intraoperatively
Discover a brand-new vision in real-time excision
Lumicell Surgeon 2
View the data
Proven effectiveness in a clinical trial setting
Lumicell Animation 1
previous arrow
next arrow

How it Works

Transformative technology to evolve cancer surgery

Lumicell is on a mission to transform cancer surgery. Our fluorescence imaging technology is designed to illuminate residual cancer in real-time.

Learn more about our new breast cancer indication

Lumicell News